This project has been flagged by a community member as inappropriate due to reason below.*

Expert Interview

Slingshot members are talking to an expert! The topic is:

A Second Opinion: Discussing the recently launched Obsidio Conformable Embolic from Boston Scientific for bleeding control

Ticker(s): BSX

Who's the expert?

Institution: Midwest Radiology

  • Interventional Radiologist at Midwest Radiology 
  • Vascular Radiology specialist who manages over 50 patients a month with embolic agents for bleeding control
  • Medical Device and Radiology consultant who has utilized the Obsidio Conformable Embolic in practice

Interview Questions
Q1.

Describe your background and practice setting

Added By: ben_admin
Q2.

How many patients do you manage for bleeding monthly?

Added By: ben_admin
Q3.

What are the different devices you use for controlling bleeding?

Added By: ben_admin
Q4.

What is your opinion of the recently launched Obsidio Conformable Embolic from BSX?

Added By: ben_admin
Q5.

Do you anticipate using the Obsidio Conformable Embolic in the future? For how many patients?

Added By: ben_admin
Q6.

Rank your excitement for the Obsidio Conformable Embolic on a scale of 1-10

Added By: ben_admin

Are You Interested In These Questions?

Slingshot Insights Explained

Expert research benefits investors by giving them timely access to unbiased real world perspectives on highly specialized topics. Slingshot Insights' crowdfunded model makes this access available at a fraction of the cost of other expert networks.

Reason

*Slingshot Insights provides access to information, not investment advice. We work to support you and facilitate access to experts; however we are not responsible for monitoring calls for the disclosure of MNPI. You should obtain financial, legal and tax advice from your qualified and licensed advisers before deciding to invest in any security.